UNSPSC 51334305: Thiothixene or tiotixene

This classification denotes an antipsychotic agent with the molecular formula C23H29N3O2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7318FJ13YJ, chemically known as cp-12,252-1 base but generally known as thiothixene, which bears US NIH Compound Identifier 5454. European Medicines Agency schedules Tiotixene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11094MIG.

The term TIOTIXENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules thiothixene in its Anatomical Therapeutic Chemical (ATC) Classification. Thiothixene or tiotixene bears US NLM identifiers UMLS ID C0039955 and NCI Concept Code C47752. SMILES: CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C.

UNSPSC 51334305 Thiothixene or tiotixene is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS, released June 30, 2026 with a response deadline of July 26, 2023—solicits naloxone and safe drug deactivation systems for community health initiatives, not thiothixene, an antipsychotic pharmaceutical. The opportunity calls for 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their proposals, maintain workers' compensation and commercial general liability insurance, comply with E-Verify requirements, and meet drug-free workplace certification standards. The contract carries an initial two-year term with a one-year renewal option and a three-month probationary period allowing termination at will. Potential FEMA funding introduces additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

The code shows minimal recent state and local procurement activity under its intended pharmaceutical scope. The single Seminole County opportunity represents a county-level health department procurement but is misclassified—it addresses opioid overdose response rather than antipsychotic medication procurement. Geographic spread cannot be reliably characterized from a single misaligned opportunity, and no additional issuing bodies or jurisdictions are evident in the available records. Business development professionals evaluating actual thiothixene or related antipsychotic procurement should verify that opportunities are correctly tagged to this code, as current classification appears unreliable for identifying genuine demand.